Epicur Pharma
Veterinary-focused pharmaceutical company operating an FDA 503B registered compounding facility and affiliated 503A pharmacy. Provides compounded sterile preparations and a portfolio of veterinary dosage forms (ophthalmics, injections, oral liquids, tablets, oncology, equine, and research-animal products). Maintains cGMP production, analytical testing for product quality, online ordering for practices, and educational resources (webinars, tip sheets, and guides).
Industries
Nr. of Employees
medium (51-250)
Epicur Pharma
Mount Laurel, New Jersey, United States
Products
Ophthalmic formulations
Bottled ophthalmic preparations for veterinary use with tested quality and stability specifications.
Injectable preparations
Sterile injectable veterinary medications produced for clinic use.
Oral liquids and tablets
Oral liquid formulations and tablet dosage forms for veterinary therapeutics, including standard-strength products and oncology tablets.
Equine products and formulations
Medication formulations tailored for equine use and clinical scenarios (including compounds relevant to equine gastric ulcer management).
Laboratory and research-animal preparations
Formulated compounds intended for use in laboratory and research-animal settings.
Ophthalmic formulations
Bottled ophthalmic preparations for veterinary use with tested quality and stability specifications.
Injectable preparations
Sterile injectable veterinary medications produced for clinic use.
Oral liquids and tablets
Oral liquid formulations and tablet dosage forms for veterinary therapeutics, including standard-strength products and oncology tablets.
Equine products and formulations
Medication formulations tailored for equine use and clinical scenarios (including compounds relevant to equine gastric ulcer management).
Laboratory and research-animal preparations
Formulated compounds intended for use in laboratory and research-animal settings.
Services
Provision of compounded sterile and non-sterile veterinary medications intended for in-clinic/office use, produced under cGMP standards.
Dispensing of patient-specific compounded prescriptions through a traditional compounding pharmacy channel.
Account setup, online ordering, and portal access for office orders and prescription refills via integrated ordering platforms.
Live and on-demand webinars, downloadable guides, and blog articles focused on clinical topics and regulatory best practices for veterinary professionals.
Provision of compounded sterile and non-sterile veterinary medications intended for in-clinic/office use, produced under cGMP standards.
Dispensing of patient-specific compounded prescriptions through a traditional compounding pharmacy channel.
Account setup, online ordering, and portal access for office orders and prescription refills via integrated ordering platforms.
Live and on-demand webinars, downloadable guides, and blog articles focused on clinical topics and regulatory best practices for veterinary professionals.
Expertise Areas
- Veterinary compounding and 503B manufacturing
- 503A patient-specific compounding and dispensing
- cGMP pharmaceutical manufacturing
- Analytical testing and QA/QC
Key Technologies
- Compounded sterile preparations (CSPs)
- cGMP-compliant manufacturing processes
- Sterility testing (microbiological assays)
- Analytical testing for potency, identity, purity, and stability
News & Updates
Upcoming webinar on evidence-based approaches to managing Equine Gastric Ulcer Syndrome in performance horses.
Article discussing differences in compounded ophthalmic products and the impact of formulation, testing, and dating on clinical outcomes.
Blog index and educational content on ophthalmic medication quality and sourcing decisions.
Explainer post on 503B-manufactured drugs and differences compared with other compounding pathways.
Upcoming webinar on evidence-based approaches to managing Equine Gastric Ulcer Syndrome in performance horses.
Article discussing differences in compounded ophthalmic products and the impact of formulation, testing, and dating on clinical outcomes.
Blog index and educational content on ophthalmic medication quality and sourcing decisions.
Explainer post on 503B-manufactured drugs and differences compared with other compounding pathways.